Industries
|
Companies
|
Filings
|
News
|
CaseLaw
|
Annual Reports
|
UK
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Latest 15-12G SEC Filings
Securities registration termination [Section 12(g)]
GENZYME DEVELOPMENT PARTNERS L P, 15-12G, 2001-01-17
MOLECULAR BIOSYSTEMS INC, 15-12G, 2001-01-04
AQUILA BIOPHARMACEUTICALS INC, 15-12G, 2000-11-17
CISTRON BIOTECHNOLOGY INC, 15-12G, 2000-11-08
EPITOPE INC/OR/, 15-12G, 2000-10-03
DIATIDE INC, 15-12G, 1999-11-03
CENTOCOR INC, 15-12G, 1999-10-13
METRA BIOSYSTEMS INC, 15-12G, 1999-08-11
INNOVIR LABORATORIES INC, 15-12G, 1999-03-31
MALLINCKRODT INC /MO, 15-12G, 1999-02-17
GAMMA BIOLOGICALS INC, 15-12G, 1999-01-22
IMMUCOR INC, 15-12G, 1998-12-18
INTERNATIONAL MUREX TECHNOLOGIES CORP, 15-12G, 1998-07-10
SEQUANA THERAPEUTICS INC, 15-12G, 1998-01-09
INVITRO INTERNATIONAL /, 15-12G, 1997-10-10
INCSTAR CORP, 15-12G, 1997-06-30
CYTOGEN CORP, 15-12G, 1997-04-09
NEOPROBE CORP, 15-12G, 1996-12-23
INTERNATIONAL CANINE GENETICS INC, 15-12G, 1996-11-04
DADE INTERNATIONAL INC, 15-12G, 1996-07-03
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission
